About the Authors
- Amber Dahlin
-
* E-mail: amber.dahlin@channing.harvard.edu
Affiliation Channing Division of Network Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States of America
- Augusto Litonjua
-
Affiliations Channing Division of Network Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States of America, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America
- John J. Lima
-
Affiliation Nemours Children’s Clinic, Jacksonville, FL, United States of America
- Mayumi Tamari
-
Affiliation Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan
- Michiaki Kubo
-
Affiliation Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan
- Charles G. Irvin
-
Affiliation University of Vermont, Burlington, VT, United States of America
- Stephen P. Peters
-
Affiliation Wake Forest School of Medicine, Winston-Salem, NC, United States of America
- Kelan G. Tantisira
-
Affiliations Channing Division of Network Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States of America, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America
Competing Interests
GlaxoSmithKline supported the conduct of the LOCCS Trial by providing funds to the American Lung Association. The authors received no relevant funding or financial support from GSK. There are no patents, products in development or marketed products related to this manuscript to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KGT AL AD. Performed the experiments: AD KGT. Analyzed the data: AD KGT MT MK AL. Contributed reagents/materials/analysis tools: SPP CGI JJL KGT AL. Wrote the paper: AD AL JJL KGT.